alexa Farmacogenetics And Herbal Medicines | 14333
ISSN: 2327-5162

Alternative & Integrative Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Conference and Exhibition on Traditional & Alternative Medicine

Diadelis Remirez Figueredo
Posters: Altern Integ Med
DOI: 10.4172/2327-5162.S1.003
Abstract
The science of pharmacogenomics has advanced significantly in the last five years, but it is still in infancy and is mostly used on research basis. The pharmacogenomics helps identify interindividual variabilities in drug response (both toxicity and effectiveness). Due to the fast growing in the consumption of phytomedicines, it is necessary the investigation of mechanism of actions of these products with more rigor. The herbal medicines like synthetic drugs have been showed their bioactivation through cytochrome P-450, the main enzyme involved in the metabolism of xenobiotics. In this work, the main enzymes involved in the metabolism of phytomedicines, the advantages and disadvantages of bioactivation to metabolites less or more toxics are described as well as the pharmacodynamic interactions involving herbs. Moreover, the herbs which affect the P-glycoprotein activity in vitro will be showed. These studies strengthen and optimize the safety of herbal medicines. The hope for the future is that through personalized medicine, doctors and patients will be able to make better-informed choices about treatment. This treatment will avoid the adverse drug reaction to the medication and will improve the diagnosis diseases as well as the prevention and treatment of diseases.
Biography
Diadelis Remirez Figueredo received her B.A. (1995, Biochemistry) from Faculty of Biology, Havana University, Cuba, and both her M.Sc. (1995, Biomedicine) and Ph.D. (1999 Pharmaceutical Sciences) from National Center for Scientific Research in Havana, and most of the results were done in the Department of Toxicology at the Free University in Amsterdam. Postdoctoral training in Molecular Toxicology and Pharmacology was completed at the Faculty of Pharmacy in Toronto, Canada. She spent 12 years working at the National Center for Scientific Research in the Pharmacology department. Since 2002, she has been working at the National Centre for State Quality of Drugs and Medical Devices, she has acted as referee for Ph.D. thesis and she is an adjunct member of Pharmaceutical Sciences Ph.D. thesis Jury. She has been referee of scientific journals related with natural products. Her other previous academic appointments include lecturer in different international meetings. She has been the recipient of National Award of Pharmacology twice from the Cuban Pharmacology Society. In recent years, she has been a member of the Scientific Advisory Council of the Centre that she works. She worked as expert for the evaluation of preclinical platform in South Africa, Council for Scientific Industrial Research (CSIR). She is currently the vice president of Cuban Pharmacology Society. She has been involved in the reorganization of Latin American Society and in the organization of different international and local congress. Her research interests have included in vitro and in vivo evaluation of hepatoprotective, antiinflamatory and antioxidant effects of Cuban synthetic and natural compounds, and investigation of the molecular cytotoxic mechanism involved in drug toxicity. At present in the Regulatory Agency, she is one of the reviewers for authorization of clinical trials, and the evaluation of safety and efficacy of drugs for registering. Besides that, she is the project leader for Pharmacogenetic guideline. Her research is described in over 30 published research reports.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7